bcrx stock 5 year forecast

Close price at the end of the last trading day Friday 16th Sep 2022 of the BCRX stock was 1315. In 2021 BCRXs revenue was 15717 million an increase of 78238 compared to the previous years 1781 million.


Ema Grants Prime Designation For Biocryst S Alk 2 Inhibitor Bcx9250

BCRX stock forecasts by analyst.

. The weighted average target price per BioCryst Pharmaceuticals share in Dec 2023 is. The order is the final of five purchase options of a 347M contract by the Centers for Disease Control and Prevention in 2018 to get up to 50k doses of Rapivab over five years. Get Free BCRX Updates.

Biocryst Pharmaceuticals BCRX stock forecast for 2022 2027. Be the first to know when Wall Street analysts revise their BCRX stock forecasts and price targets. BCRX stock forecast Our latest prediction for Biocryst Pharmaceuticals Incs stock price was made on the Nov.

BCRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. This is 249 more than the trading day before Thursday 15th Sep 2022. The Score for BCRX is 58 which is 16 above its historic median score of 50 and infers lower risk than normal.

DOCU one year forecast. For BioCryst Pharmaceuticals stock forecast for 2027 5 year 12 predictions are offered for each month of 2027 with average BioCryst Pharmaceuticals stock forecast. Revenue growth last year.

BCRX from the largest community of traders and investors. 23 2021 when the stock price was at 1237. According to 18 stock analysts the average 12-month stock price forecast for BCRX stock is 1867 which predicts an increase of 4817.

Stock forecast for tomorrow and next 5. An downtrend is forecast for this month with an optimal target price of 129747. Rooms Rankings Earnings Newsletters Shop.

1337 D 155 021. Get an edge in the market with our BioCryst Pharmaceuticals Inc. In Dec the positive dynamics for Momo shares will prevail with possible monthly volatility of 10985 volatility is expected.

Losses were -18406 million 068. Find real-time BCRX - BioCryst Pharmaceuticals Inc stock quotes company profile news and forecasts from CNN Business. Stock Price Forecast.

As of 2022 October 08 Saturday current price of BCRX stock is 13895 and our data indicates that the asset price. Get the latest BCRX stock forecast powered by the most important price indicators. Next 5 years 511.

About the BioCryst Pharmaceuticals Inc. The current BioCryst Pharmaceuticals BCRX share price is 1260. DocuSign stock monthly and weekly forecasts.

In Dec the negative dynamics for Momo shares will prevail with possible. DOCU share price prediction for 2022 2023 2024 2025 2026 and 2027. BioCryst Pharmaceuticals Stock Prediction for Nov 2022.

Real-time trade and investing ideas on Biocryst Pharmaceuticals Inc. Find the latest BioCryst Pharmaceuticals Inc. The weighted average target price per BioCryst Pharmaceuticals share in Dec 2026 is.

According to latest technical analysis BioCryst Pharmaceuticals stock forecast for 2022 is 1719 forecast for 2023 is 1946 forecast for 2024 is 1963 forecast for 2025 is 1958 forecast for 2026 is 1955 forecast for 2027 is 1905 forecast for 2028 is 1922 forecast for 2029 is 191 forecast for 2030 is 1901 and forecast.


There S An Opportunity Brewing In Biocryst Stock Says Analyst


Bcrx Insider Trading Biocryst Pharmaceuticals Inc Secform4 Com


Biocryst Pharmaceuticals Inc Trade Ideas Nasdaq Bcrx Tradingview


Bcrx Dd The Embarrassment Of Riches R Wallstreetbets


Biocryst Short Sellers Lose Control Nasdaq Bcrx Seeking Alpha


Roivant Sciences Nasdaqgm Roiv Share Price News Analysis Simply Wall St


Bcrx Stock News Biocryst Pharmaceuticals Big Breakout Youtube


Bcrx Tradingview


Page 5 Biocryst Pharmaceuticals Inc Trade Ideas Nasdaq Bcrx Tradingview


Bcrx 22 Short Squeeze It S Fucking Real Loaded And The Margin Calls Are Beginning Today R Wallstreetbets


Bcrx Biocryst Pharmaceuticals Inc Dividend History Dividend Channel


Biocryst Stock A Prudent Diversification Nasdaq Bcrx Seeking Alpha


Biocryst Bcrx Pauses Enrolment In Key Studies Stock Down


Main Reasons Why I Would Invest In Bcrx Before Q2 Er R Wallstreetbets


Biocryst Pharmaceuticals Inc S Nasdaq Bcrx Recent 3 5 Pullback Adds To One Year Year Losses Institutional Owners May Take Drastic Measures Nasdaq


Wmcsgxev3adgsm


Biocryst Pharmaceuticals Inc Trade Ideas Nasdaq Bcrx Tradingview


Why Biocryst Stock Lost Nearly 4 Of Its Value Today The Motley Fool


3 Biotech Stocks Under 4 With Big Upside Potential Nasdaq

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel